4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AuBEX CORPORATION (3583) operates in the Department Stores industry and is headquartered in Tokyo, Japan with about 353 employees. Its market capitalization is roughly JPY 3 billion. In the fiscal year ended 2026-03-31, 3583 reported JPY 6.0B in revenue and JPY 573M in net income.
AuBEX CORPORATION manufactures and sells nibs and medical equipment in Japan and internationally. The company offers nibs made from chemical fibers, plastics, and other material; medical equipment and components, such as pressure infusion devices and angiography guide wires; and nibs for makeup and cosmetics products.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 6.0B | JPY 6.0B | JPY 5.4B | JPY 5.3B | — |
| Gross Profit | JPY 2.0B | JPY 2.3B | JPY 1.9B | JPY 1.9B | — |
| Operating Income (EBIT) | JPY 615M | JPY 841M | JPY 561M | JPY 623M | — |
| Net Income | JPY 573M | JPY 580M | JPY 436M | JPY 469M | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 100M) | (JPY 61M) | (JPY 62M) | (JPY 77M) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets | JPY 10.2B | JPY 9.8B | JPY 9.7B | JPY 9.3B |
| Total Liabilities | JPY 2.9B | JPY 3.1B | JPY 3.5B | JPY 3.5B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3583 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms